- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Deutsch
- Bibliographic citation
-
Juvenile Uveitis ; volume:38 ; number:5 ; day:27 ; month:2 ; year:2024 ; pages:191-208 ; date:10.2024
Spektrum der Augenheilkunde ; 38, Heft 5 (27.2.2024), 191-208, 10.2024
- Keyword
-
Uveitis
Kind
Augenkrankheit
Intermediäre Uveitis
- Creator
-
Eidherr, Markus
Jarz-Lackner, Hildrun
Bolz, Matthias
Barisani-Asenbauer, Talin
Strauß, Rupert W.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00717-023-00567-8
- URN
-
urn:nbn:de:101:1-2501061035262.942244972934
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:32 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Eidherr, Markus
- Jarz-Lackner, Hildrun
- Bolz, Matthias
- Barisani-Asenbauer, Talin
- Strauß, Rupert W.
- SpringerLink (Online service)
Other Objects (12)
Juvenile idiopathic arthritis-associated uveitis
Juvenile Spondyloarthritis: focus on uveitis
Uveitis associated with juvenile arthritis: a continued cohort study 40 years after uveitis onset
Juvenile idiopathische Arthritis: Gelenk- und Uveitis-Schübe oft gleichzeitig
Perinatal events and development of juvenile idiopathic arthritis-associated uveitis
Golimumab in juvenile idiopathic arthritis-associated uveitis unresponsive to Adalimumab
Knowledge about juvenile idiopathic arthritis-associated uveitis: more frequent reminders are associated with higher patient and family uveitis knowledge
Immunomodulatory treatment and surgical management of idiopathic uveitis and juvenile idiopathic arthritis-associated uveitis in children: a French survey practice
Discontinuing adalimumab in patients with controlled juvenile idiopathic arthritis-associated uveitis (ADJUST—Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial): study protocol for a randomised controlled trial
Adalimumab treatment in Juvenile Idiopathic Arthritis (JIA) patients with special focus on Uveitis
Juvenile idiopathic arthritis-associated uveitis: a retrospective analysis from a centre of South Italy
Efficacy of adalimumab in refractory juvenile idiopathic arthritis related uveitis: report of 6 cases
Juvenile idiopathic arthritis-associated uveitis
Juvenile Spondyloarthritis: focus on uveitis
Uveitis associated with juvenile arthritis: a continued cohort study 40 years after uveitis onset
Juvenile idiopathische Arthritis: Gelenk- und Uveitis-Schübe oft gleichzeitig
Perinatal events and development of juvenile idiopathic arthritis-associated uveitis
Golimumab in juvenile idiopathic arthritis-associated uveitis unresponsive to Adalimumab
Knowledge about juvenile idiopathic arthritis-associated uveitis: more frequent reminders are associated with higher patient and family uveitis knowledge
Immunomodulatory treatment and surgical management of idiopathic uveitis and juvenile idiopathic arthritis-associated uveitis in children: a French survey practice
Discontinuing adalimumab in patients with controlled juvenile idiopathic arthritis-associated uveitis (ADJUST—Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial): study protocol for a randomised controlled trial
Adalimumab treatment in Juvenile Idiopathic Arthritis (JIA) patients with special focus on Uveitis
Juvenile idiopathic arthritis-associated uveitis: a retrospective analysis from a centre of South Italy
Efficacy of adalimumab in refractory juvenile idiopathic arthritis related uveitis: report of 6 cases
Juvenile idiopathic arthritis-associated uveitis
Juvenile Spondyloarthritis: focus on uveitis
Uveitis associated with juvenile arthritis: a continued cohort study 40 years after uveitis onset
Juvenile idiopathische Arthritis: Gelenk- und Uveitis-Schübe oft gleichzeitig
Perinatal events and development of juvenile idiopathic arthritis-associated uveitis
Golimumab in juvenile idiopathic arthritis-associated uveitis unresponsive to Adalimumab
Knowledge about juvenile idiopathic arthritis-associated uveitis: more frequent reminders are associated with higher patient and family uveitis knowledge
Immunomodulatory treatment and surgical management of idiopathic uveitis and juvenile idiopathic arthritis-associated uveitis in children: a French survey practice
Discontinuing adalimumab in patients with controlled juvenile idiopathic arthritis-associated uveitis (ADJUST—Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial): study protocol for a randomised controlled trial
Adalimumab treatment in Juvenile Idiopathic Arthritis (JIA) patients with special focus on Uveitis
Juvenile idiopathic arthritis-associated uveitis: a retrospective analysis from a centre of South Italy